Results 141 to 150 of about 130,824 (258)

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Group 2 innate lymphoid cells: Where are we 15 years out? [PDF]

J Allergy Clin Immunol
Doherty TA.
europepmc   +1 more source

Microbiome and Tumor Microenvironment Interactions: Advances From Ecological Niches to Precision Oncology

Cancer Nexus, EarlyView.
Tumor‐associated microbiota occupies spatially organized ecological niches and influence cancer progression by reshaping tumor‐cell signaling, metabolism, immunity, stromal remodeling, and therapeutic response. Integrating microbiome‐derived biomarkers, targeted microbial interventions, spatial multi‐omics, longitudinal monitoring, and AI may enable ...
Yiwen Zhang, Ji'an Liu, Jing Li, Xue Liu, Yang Su, Peng Luo, Yuhan Zhang, Zhengrui Li   +7 more
wiley   +1 more source

Commentary: Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation

Frontiers in Immunology, 2018
Boning Zeng, Boning Zeng, Shengnan Shi, Jing Liu, Feiyue Xing, Feiyue Xing   +5 more
doaj   +1 more source

IL-10-producing innate lymphoid cells restrain γδT17-driven psoriatic inflammation. [PDF]

iScience
Jo MG, Choi MY, Min KY, Park JW, Shin J, Lee JA, Hwang S, Noh G, Kim YM, Choi WS, Kim HS.   +10 more
europepmc   +1 more source

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Routine TBNK immunophenotyping detects the major lymphocyte compartments but may underestimate the biologically relevant variation contributed by less frequent but well‐defined minor lymphocyte subsets. This study evaluated whether extending routine TBNK immunophenotyping with minor lymphocyte subsets provides complementary, analytically ...
Carlos Agustin Villegas Valverde, Yendry Ventura Carmenate, Vianed Marsan Suarez, Yandy Marx Castillo Aleman, Imilla Casado Hernandez, Rachely Hernandez Corrales   +5 more
wiley   +1 more source

Author Correction: Peyer's patch M cells organize an epithelial niche that sustains group 3 innate lymphoid cells and IL-22. [PDF]

Nat Immunol
Cao WHJ, You Y, Wang N, Chaudhry MZ, Yu H, Bell PT, Noye EC, Denman R, Lee B, Waddington A, Ye J, Schreuder J, Huang Q, Tellier J, Curio S, Santiago J, Amann-Zalcenstein D, Jacquelot N, Hickey P, Nutt SL, Seillet C, Hansbro PM, Wimmer VC, Strugnell RA, Tuong ZK, Ritchie ME, Belz GT.   +26 more
europepmc   +1 more source

A practical difference from the normal approach to evaluate natural killer (NK) cells and NK cell neoplasms by flow cytometry

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Natural killer (NK) cell neoplasms span indolent to highly aggressive entities, and flow cytometric immunophenotyping is central to their detection and classification. However, distinguishing reactive from neoplastic NK cell expansions can be challenging because NK cells lack somatically recombined antigen receptors, and reactive states may ...
Aaron J. Wilk, Afshin Shameli, Erik Ames, Jonathan R. Fromm, Bartosz Grzywacz, Min Shi, Sindhu Cherian, Jean Oak   +7 more
wiley   +1 more source

Editorial: Transcriptional and post-transcriptional regulatory networks in cellular homeostasis and stress response

Frontiers in Molecular Biosciences
Alessandra Boccaccini, Davide Capauto, Matteo Cassandri, Silvia Santopolo   +3 more
doaj   +1 more source

Plasticity and antigen presentation by group 3 innate lymphoid cells in colorectal cancer. [PDF]

Front Immunol
Qiao L, Zhang J, Li J, Li X, He X, Zhang M, Lu J, Zhang X, Dong J, Tao G, Wang Y, Cui J, Bao L, Zhao P.   +13 more
europepmc   +1 more source